RNA-Seq data analysis of CRISPR/Cas9 knockout of the PRLR in HR+ breast cancer cells revealed the oncogenic CCN2 gene as the most upregulated target gene, highlighting an antagonistic relationship between PRLR and CCN2 gene expression. This evidence concerns the gene PRLR and breast carcinoma.